Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Bateman

Showing results (91-100 of 100) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 100 results.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|August 29, 2017
Insulin glargine and its two active metabolites: A sensitive (16pM) and robust simultaneous hybrid assay coupling immunoaffinity purification with LC-MS/MS to support biosimilar clinical studiesYang Xu, Li Sun, Melanie Anderson, et al.
The AAPS Journal|April 6, 2022
An Investigation of Instability in Dried Blood Spot Samples for Pharmacokinetic Sampling in Phase 3 Trials of VerubecestatMelanie Anderson, Marissa F Dockendorf, Ian McIntosh, et al.
Journal of Clinical Pharmacology|November 15, 2017
Population PK Analyses of Ubrogepant (MK-1602), a CGRP Receptor Antagonist: Enriching In-Clinic Plasma PK Sampling With Outpatient Dried Blood Spot SamplingChi-Chung Li, Marissa Dockendorf, Ken Kowalski, et al.
Clinical Pharmacology and Therapeutics|June 10, 2018
Leveraging Digital Health Technologies and Outpatient Sampling in Clinical Drug Development: A Phase I Exploratory StudyMarissa F Dockendorf, Gowri Murthy, Kevin P Bateman, et al.
Analytical Chemistry|April 5, 2021
Direct Analysis from Phase-Separated Liquid Samples using ADE-OPI-MS: Applicability to High-Throughput Screening for Inhibitors of Diacylglycerol Acyltransferase 2Xiujuan Wen, Chang Liu, Lucien Ghislain, et al.
Bioorganic & Medicinal Chemistry Letters|April 10, 2007
Metabolic activation of indole-containing prostaglandin D2 receptor 1 antagonists: impacts of glutathione trapping and glucuronide conjugation on covalent bindingJean-François Lévesque, Stephen H Day, Nathalie Chauret, et al.
Journal of the American Chemical Society|July 12, 2024
High-Throughput Covalent Modifier Screening with Acoustic Ejection Mass SpectrometryXiujuan Wen, Chang Liu, Kiersten Tovar, et al.
Clinical Pharmacology and Therapeutics|December 13, 2016
Validation of a microdose probe drug cocktail for clinical drug interaction assessments for drug transporters and CYP3AT Prueksaritanont, D A Tatosian, X Chu, et al.
Bioorganic & Medicinal Chemistry Letters|January 12, 2010
The discovery of MK-0674, an orally bioavailable cathepsin K inhibitorElise Isabel, Kevin P Bateman, Nathalie Chauret, et al.
Journal of Medicinal Chemistry|February 16, 2007
Discovery of a potent and selective prostaglandin D2 receptor antagonist, [(3R)-4-(4-chloro-benzyl)-7-fluoro-5-(methylsulfonyl)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl]-acetic acid (MK-0524)Claudio F Sturino, Gary O'Neill, Nicolas Lachance, et al.
Pageof 10

Showing results (91-100 of 100) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 100 results.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|August 29, 2017
Insulin glargine and its two active metabolites: A sensitive (16pM) and robust simultaneous hybrid assay coupling immunoaffinity purification with LC-MS/MS to support biosimilar clinical studiesYang Xu, Li Sun, Melanie Anderson, et al.
The AAPS Journal|April 6, 2022
An Investigation of Instability in Dried Blood Spot Samples for Pharmacokinetic Sampling in Phase 3 Trials of VerubecestatMelanie Anderson, Marissa F Dockendorf, Ian McIntosh, et al.
Journal of Clinical Pharmacology|November 15, 2017
Population PK Analyses of Ubrogepant (MK-1602), a CGRP Receptor Antagonist: Enriching In-Clinic Plasma PK Sampling With Outpatient Dried Blood Spot SamplingChi-Chung Li, Marissa Dockendorf, Ken Kowalski, et al.
Clinical Pharmacology and Therapeutics|June 10, 2018
Leveraging Digital Health Technologies and Outpatient Sampling in Clinical Drug Development: A Phase I Exploratory StudyMarissa F Dockendorf, Gowri Murthy, Kevin P Bateman, et al.
Analytical Chemistry|April 5, 2021
Direct Analysis from Phase-Separated Liquid Samples using ADE-OPI-MS: Applicability to High-Throughput Screening for Inhibitors of Diacylglycerol Acyltransferase 2Xiujuan Wen, Chang Liu, Lucien Ghislain, et al.
Bioorganic & Medicinal Chemistry Letters|April 10, 2007
Metabolic activation of indole-containing prostaglandin D2 receptor 1 antagonists: impacts of glutathione trapping and glucuronide conjugation on covalent bindingJean-François Lévesque, Stephen H Day, Nathalie Chauret, et al.
Journal of the American Chemical Society|July 12, 2024
High-Throughput Covalent Modifier Screening with Acoustic Ejection Mass SpectrometryXiujuan Wen, Chang Liu, Kiersten Tovar, et al.
Clinical Pharmacology and Therapeutics|December 13, 2016
Validation of a microdose probe drug cocktail for clinical drug interaction assessments for drug transporters and CYP3AT Prueksaritanont, D A Tatosian, X Chu, et al.
Bioorganic & Medicinal Chemistry Letters|January 12, 2010
The discovery of MK-0674, an orally bioavailable cathepsin K inhibitorElise Isabel, Kevin P Bateman, Nathalie Chauret, et al.
Journal of Medicinal Chemistry|February 16, 2007
Discovery of a potent and selective prostaglandin D2 receptor antagonist, [(3R)-4-(4-chloro-benzyl)-7-fluoro-5-(methylsulfonyl)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl]-acetic acid (MK-0524)Claudio F Sturino, Gary O'Neill, Nicolas Lachance, et al.
Pageof 10